TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Telomir Pharmaceuticals, Inc. ( (TELO) ).
On August 28, 2025, Telomir Pharmaceuticals, Inc. successfully completed the sale of 1,550,000 shares of its common stock to institutional investors at an average price of $1.87 per share, generating gross proceeds of approximately $2.9 million. This transaction, facilitated through Rodman & Renshaw via the StockBlock platform, was conducted without the inclusion of any warrants and reflects a premium to the prior day’s closing price, potentially indicating strong investor confidence and positively impacting the company’s financial position.
The most recent analyst rating on (TELO) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Telomir Pharmaceuticals, Inc. stock, see the TELO Stock Forecast page.
More about Telomir Pharmaceuticals, Inc.
Average Trading Volume: 4,527,206
Technical Sentiment Signal: Sell
Current Market Cap: $38.74M
Find detailed analytics on TELO stock on TipRanks’ Stock Analysis page.